TrialCancer immunology, immunotherapy : CII2026

A novel oncolytic herpes simplex virus type 2 induces polarization of tumor-associated macrophages and remodels the immune microenvironment in glioblastoma.

Xin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.